The Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update for September 2009 (PDF).
This issue contains Hot Topics on the possible association between insulin glargine and an increased risk of cancer, an update on the efficacy of measures implemented to reduce risk of illicit use of ephedrine and pseudoephedrine and information about the new warnings and tighter controls for codeine and dihydrocodeine containing analgesics.
Additionally, there is a Stop Press regarding the interaction between proton pump inhibitors and clopidogrel that clarifies alternative gastrointestinal therapies should not include cimetidine.
Action: Clinicians will find this publication to be a useful review of current issues in drug safety.
|« OTC analgesic advice||Generic topiramate »|